The study is designed to observe the use of a peptide-based oral nutrition supplement in adults with chronic malabsorption or maldigestion who require supplemental nutrition as assessed by a clinician.

Inclusion Criteria:

• Subject is ≥ 18 years of age.
• Subject has chronic malabsorption or maldigestion.
• Subject requires supplemental nutrition as assessed by a clinician.
• Subject agrees to consume 2 servings of the study product a day for at least 16 consecutive days during Treatment period.

Exclusion Criteria:

• Subject is currently taking or has taken antibiotics within 2 weeks prior to enrollment in the study.
• Subject has current active malignant disease or was treated within the last 6 months for cancer.
• Subject has a history of diabetes mellitus.
• Subject is pregnant as demonstrated by a urine pregnancy test.
• Subject has severe auto immune disease and is on immuno-modulating therapy.
• Subject has a history of allergy to any of the ingredients in the study product.
• Subject has active HIV.
• Subject has a known aversion to flavor of product being tested.
• Subject has known dementia, brain metastases, eating disorders, history of significant neurological or psychiatric disorder, or any other psychological condition that may interfere with study product consumption.
• Subject has an obstruction of the gastrointestinal tract precluding ingestion or absorption of the study product.
• Subject is taking part in another non-Sponsor approved clinical trial.